Literature DB >> 18058092

Distribution of the GNB3 825C>T polymorphism among Brazilians: impact of population structure.

Daniela D Vargens1, Lucas Almendra, Cláudio J Struchiner, Guilherme Suarez-Kurtz.   

Abstract

OBJECTIVE: To describe the impact of population admixture on the distribution of the GNB3 825C>T polymorphism in the heterogeneous Brazilian population.
METHODS: Individual DNA from 236 healthy Brazilians, self-identified as White, Intermediate and Black, was genotyped for a set of insertion/deletion polymorphisms that have been previously validated as ancestry informative markers (AIMs). The GNB3 825C>T polymorphism was detected by PCR-RFLP. Non-linear logistic regression modeling was applied to describe the association between the GNB3 825C>T polymorphisms and the African component of ancestry (ACA) estimated by the AIMs.
RESULTS: The GNB3 825C>T allele and genotype distribution differed significantly across the three self-reported groups (P < 0.0001, chi(2) test), with a trend for increasing frequency of both the GNB3 825T allele and the TT genotype from White to Intermediate to Black individuals (P < 0.0001, chi(2) test for trend in proportions). Non-linear logistic regression showed that the odds of having the GNB3 825C>T allele increase monotonically (P < 0.0001, Wald statistics) with increasing ACA throughout the ACA range (0.136-0.897) observed in the overall population sample, irrespective of "racial/color" self-identification.
CONCLUSION: The present data on the GNB3 825C>T polymorphism support the notion that interethnic admixture, which is a source of spurious genotype-phenotype associations in pharmacogenetic/-genomic studies, must be dealt with as a continuous variable, rather than proportioned in arbitrary sub-categories for the convenience of data quantification and analysis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18058092     DOI: 10.1007/s00228-007-0413-2

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  18 in total

1.  Inference of population structure using multilocus genotype data.

Authors:  J K Pritchard; M Stephens; P Donnelly
Journal:  Genetics       Date:  2000-06       Impact factor: 4.562

2.  Color and genomic ancestry in Brazilians.

Authors:  Flavia C Parra; Roberto C Amado; José R Lambertucci; Jorge Rocha; Carlos M Antunes; Sérgio D J Pena
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-30       Impact factor: 11.205

3.  In genetic control of disease, does 'race' matter?

Authors:  David B Goldstein; Joel N Hirschhorn
Journal:  Nat Genet       Date:  2004-12       Impact factor: 38.330

4.  The genetic structure of human populations studied through short insertion-deletion polymorphisms.

Authors:  Luciana Bastos-Rodrigues; Juliana R Pimenta; Sergio D J Pena
Journal:  Ann Hum Genet       Date:  2006-09       Impact factor: 1.670

5.  Impact of population admixture on the distribution of the CYP3A5*3 polymorphism.

Authors:  Guilherme Suarez-Kurtz; Jamila A Perini; Luciana Bastos-Rodrigues; Sergio D J Pena; Cláudio Struchiner
Journal:  Pharmacogenomics       Date:  2007-10       Impact factor: 2.533

6.  Suggestive association between the C825T polymorphism of the G-protein beta3 subunit gene (GNB3) and clinical improvement with antipsychotics in schizophrenia.

Authors:  Daniel J Müller; Vincenzo De Luca; Tricia Sicard; Nicole King; Rudi Hwang; Jan Volavka; Pal Czobor; Brian B Sheitman; Jean-Pierre Lindenmayer; Leslie Citrome; Joseph P McEvoy; Jeffrey A Lieberman; Herbert Y Meltzer; James L Kennedy
Journal:  Eur Neuropsychopharmacol       Date:  2005-04-14       Impact factor: 4.600

7.  Identification and ethnic distribution of major haplotypes in the gene GNB3 encoding the G-protein beta3 subunit.

Authors:  Dieter Rosskopf; Iris Manthey; Winfried Siffert
Journal:  Pharmacogenetics       Date:  2002-04

8.  Association of a human G-protein beta3 subunit variant with hypertension.

Authors:  W Siffert; D Rosskopf; G Siffert; S Busch; A Moritz; R Erbel; A M Sharma; E Ritz; H E Wichmann; K H Jakobs; B Horsthemke
Journal:  Nat Genet       Date:  1998-01       Impact factor: 38.330

9.  Prediction of successful weight reduction under sibutramine therapy through genotyping of the G-protein beta3 subunit gene (GNB3) C825T polymorphism.

Authors:  Hans Hauner; Marion Meier; Karl-Heinz Jöckel; Ulrich H Frey; Winfried Siffert
Journal:  Pharmacogenetics       Date:  2003-08

10.  G protein beta3 polymorphism and triptan response in cluster headache.

Authors:  M Schürks; T Kurth; P Stude; C Rimmbach; J de Jesus; M Jonjic; H-C Diener; D Rosskopf
Journal:  Clin Pharmacol Ther       Date:  2007-03-14       Impact factor: 6.875

View more
  4 in total

1.  CYP2C9 and VKORC1 genotypes in Puerto Ricans: A case for admixture-matching in clinical pharmacogenetic studies.

Authors:  David Villagra; Jorge Duconge; Andreas Windemuth; Carmen L Cadilla; Mohan Kocherla; Krystyna Gorowski; Kali Bogaard; Jessica Y Renta; Irelys A Cruz; Sara Mirabal; Richard L Seip; Gualberto Ruaño
Journal:  Clin Chim Acta       Date:  2010-05-19       Impact factor: 3.786

2.  Pharmacogenetics in the brazilian population.

Authors:  Guilherme Suarez-Kurtz
Journal:  Front Pharmacol       Date:  2010-10-04       Impact factor: 5.810

3.  Distribution of CYP2D6 alleles and phenotypes in the Brazilian population.

Authors:  Deise C Friedrich; Júlia P Genro; Vinicius A Sortica; Guilherme Suarez-Kurtz; Maria Elizabete de Moraes; Sergio D J Pena; Andrea K Ribeiro dos Santos; Marco A Romano-Silva; Mara H Hutz
Journal:  PLoS One       Date:  2014-10-20       Impact factor: 3.240

4.  Pharmacogenomic Diversity among Brazilians: Influence of Ancestry, Self-Reported Color, and Geographical Origin.

Authors:  Guilherme Suarez-Kurtz; Sergio Danilo Juno Pena; Claudio José Struchiner; Mara Helena Hutz
Journal:  Front Pharmacol       Date:  2012-11-06       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.